HER Act

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3749 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
                                H. R. 3749

 To direct the Secretary of Health and Human Services to award grants 
 for research, investigation, and awareness of the effect of personal 
 care products containing endocrine-disrupting chemicals on the female 
              reproductive system, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              June 5, 2025

 Ms. Brown (for herself, Mrs. McIver, Mr. Johnson of Georgia, and Ms. 
  Pressley) introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To direct the Secretary of Health and Human Services to award grants 
 for research, investigation, and awareness of the effect of personal 
 care products containing endocrine-disrupting chemicals on the female 
              reproductive system, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Health and Endocrine Research on 
personal care products for women Act'' or the ``HER Act''.

SEC. 2. GRANTS FOR RESEARCH, INVESTIGATION, AND AWARENESS REGARDING 
              ENDOCRINE-DISRUPTING CHEMICALS IN PERSONAL CARE PRODUCTS.

    (a) Research Grants.--
            (1) In general.--The Secretary of Health and Human 
        Services, acting through the Director of the National Institute 
        of Environmental Health Sciences, shall award grants for 
        research on the impact of personal care products containing 
        endocrine-disrupting chemicals on the female reproductive 
        system and related reproductive toxicity concerns.
            (2) Reports.--Not later than 5 years after the date of 
        enactment of this Act, and every 5 years thereafter, the 
        Secretary shall submit to the Congress, and make publicly 
        available on the appropriate website of the Department of 
        Health and Human Services, a report based on the results of the 
        research under paragraph (1). Such report shall--
                    (A) outline research developments and findings 
                related to disparities in access to safe non-endocrine-
                disrupting personal care products;
                    (B) list safe and harmful personal care products, 
                as determined by the Secretary; and
                    (C) include evidence-based or evidence-informed 
                legislative or administrative strategies to increase 
                the Food and Drug Administration's domain to regulate 
                personal care product ingredients that are endocrine-
                disrupting chemicals that harm women's reproductive 
                health.
    (b) State Grants for Investigation and Awareness.--
            (1) In general.--The Secretary shall award grants to States 
        for carrying out--
                    (A) programs to investigate the impact of personal 
                care products containing endocrine-disrupting chemicals 
                on women's reproductive health; and
                    (B) programs to develop and implement public 
                awareness and education campaigns about the use of 
                alternative personal care products that are less 
                harmful to human health.
            (2) Reports.--Not later than 5 years after the initial 
        awarding of grants under paragraph (1), and every 5 years 
        thereafter, the Secretary shall submit to the Congress, and 
        make publicly available on the appropriate website of the 
        Department of Health and Human Services, a report summarizing 
        the findings and results of the programs and activities funded 
        through the grants under paragraph (1).
    (c) Definitions.--In this section:
            (1) Endocrine-disrupting chemical.--The term ``endocrine-
        disrupting chemical'' means a chemical that mimics, blocks, or 
        interferes with the body's hormones.
            (2) Personal care product.--The term ``personal care 
        product'' means a product that--
                    (A) is a cosmetic (as defined in section 201 of the 
                Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321)); 
                and
                    (B) is intended to support the hygiene, grooming, 
                or other personal care of the human body.
            (3) Secretary.--The term ``Secretary'' means the Secretary 
        of Health and Human Services.
            (4) State.--The term ``State'' means--
                    (A) each of the several States, the District of 
                Columbia, and the territories of the United States; and
                    (B) an Indian Tribe or Tribal organization (as such 
                terms are defined in section 4 of the Indian Self-
                Determination and Education Assistance Act (25 U.S.C. 
                5304)).
                                 <all>